| Galectin-3 mediates aldosterone-induced vascular fibrosis L Calvier, M Miana, P Reboul, V Cachofeiro, E Martinez-Martinez, ... Arteriosclerosis, thrombosis, and vascular biology 33 (1), 67-75, 2013 | 483 | 2013 |
| The impact of galectin-3 inhibition on aldosterone-induced cardiac and renal injuries L Calvier, E Martinez-Martinez, M Miana, V Cachofeiro, E Rousseau, ... JACC: Heart Failure 3 (1), 59-67, 2015 | 254 | 2015 |
| More than a simple biomarker: the role of NGAL in cardiovascular and renal diseases M Buonafine, E Martinez-Martinez, F Jaisser Clinical science 132 (9), 909-923, 2018 | 183 | 2018 |
| Galectin-3 blockade inhibits cardiac inflammation and fibrosis in experimental hyperaldosteronism and hypertension E Martínez-Martínez, L Calvier, A Fernández-Celis, E Rousseau, ... Hypertension 66 (4), 767-775, 2015 | 174 | 2015 |
| Leptin induces cardiac fibrosis through galectin-3, mTOR and oxidative stress: potential role in obesity E Martínez-Martínez, R Jurado-López, M Valero-Muñoz, MV Bartolomé, ... Journal of hypertension 32 (5), 1104-1114, 2014 | 142 | 2014 |
| CT-1 (cardiotrophin-1)-Gal-3 (galectin-3) axis in cardiac fibrosis and inflammation: mechanistic insights and clinical implications E Martínez-Martínez, C Brugnolaro, J Ibarrola, S Ravassa, M Buonafine, ... Hypertension 73 (3), 602-611, 2019 | 109 | 2019 |
| Neutrophil gelatinase–associated lipocalin, a novel mineralocorticoid biotarget, mediates vascular profibrotic effects of mineralocorticoids A Tarjus, E Martínez-Martínez, C Amador, C Latouche, S El Moghrabi, ... Hypertension 66 (1), 158-166, 2015 | 100 | 2015 |
| Galectin-3 participates in cardiovascular remodeling associated with obesity E Martínez-Martínez, N López-Ándres, R Jurado-López, E Rousseau, ... Hypertension 66 (5), 961-969, 2015 | 97 | 2015 |
| Aldosterone target NGAL (neutrophil gelatinase–associated lipocalin) is involved in cardiac remodeling after myocardial infarction through NFκB pathway E Martínez-Martínez, M Buonafine, I Boukhalfa, J Ibarrola, ... Hypertension 70 (6), 1148-1156, 2017 | 82 | 2017 |
| Role for Galectin‐3 in calcific aortic valve stenosis JR Sádaba, E Martínez‐Martínez, V Arrieta, V Álvarez, A Fernández‐Celis, ... Journal of the American Heart Association 5 (11), e004360, 2016 | 80 | 2016 |
| Galectin-3 blockade reduces renal fibrosis in two normotensive experimental models of renal damage E Martinez-Martinez, J Ibarrola, L Calvier, A Fernandez-Celis, C Leroy, ... PLoS One 11 (11), e0166272, 2016 | 77 | 2016 |
| The lysyl oxidase inhibitor (β-aminopropionitrile) reduces leptin profibrotic effects and ameliorates cardiovascular remodeling in diet-induced obesity in rats E Martínez-Martínez, C Rodríguez, M Galán, M Miana, R Jurado-López, ... Journal of molecular and cellular cardiology 92, 96-104, 2016 | 77 | 2016 |
| The potential role of leptin in the vascular remodeling associated with obesity E Martínez-Martínez, M Miana, R Jurado-López, MV Bartolomé, ... International journal of obesity 38 (12), 1565-1572, 2014 | 72 | 2014 |
| The lysyl oxidase inhibitor β-aminopropionitrile reduces body weight gain and improves the metabolic profile in diet-induced obesity in rats M Miana, M Galán, E Martínez-Martínez, S Varona, R Jurado-López, ... Disease models & mechanisms 8 (6), 543-551, 2015 | 69 | 2015 |
| Galectin-3 inhibition prevents adipose tissue remodelling in obesity E Martínez-Martínez, L Calvier, P Rossignol, E Rousseau, ... International journal of obesity 40 (6), 1034-1038, 2016 | 65 | 2016 |
| Neutrophil Gelatinase-Associated Lipocalin from immune cells is mandatory for aldosterone-induced cardiac remodeling and inflammation M Buonafine, E Martínez-Martínez, C Amador, B Gravez, J Ibarrola, ... Journal of Molecular and Cellular Cardiology 115, 32-38, 2018 | 63 | 2018 |
| The endothelial αENaC contributes to vascular endothelial function in vivo A Tarjus, M Maase, P Jeggle, E Martinez-Martinez, C Fassot, L Loufrani, ... PloS one 12 (9), e0185319, 2017 | 56 | 2017 |
| A role for soluble ST2 in vascular remodeling associated with obesity in rats E Martinez-Martinez, M Miana, R Jurado-Lopez, E Rousseau, ... PLoS One 8 (11), e79176, 2013 | 55 | 2013 |
| Galectin-3 pharmacological inhibition attenuates early renal damage in spontaneously hypertensive rats E Martínez-Martínez, J Ibarrola, A Fernández-Celis, L Calvier, C Leroy, ... Journal of hypertension 36 (2), 368-376, 2018 | 53 | 2018 |
| Galectin-3 down-regulates antioxidant peroxiredoxin-4 in human cardiac fibroblasts: a new pathway to induce cardiac damage J Ibarrola, V Arrieta, R Sádaba, E Martinez-Martinez, A Garcia-Peña, ... Clinical Science 132 (13), 1471-1485, 2018 | 49 | 2018 |
